About Sharon Laboratories
Sharon Laboratories is a Chemicals & Materials company based in Ashdod (Israel) founded in 1977, and was acquired by Tene Investment Funds in March 2017. Diversified chemical preservatives are supplied for industrial applications. Sharon Laboratories has completed 1 acquisition, including Res Pharma Innovative Ingredients. Its chief executive, as recorded, is Ari Melamud. Its focus areas include Chemicals and Materials, Chemical Preservatives, Cosmetics and Green Preservatives. Its legal entity is IBLbet Incorporated.
Company details
Sharon Laboratories was founded in 1977 in Ashdod, Israel, within the chemical sector. Diversified preservatives are developed and provided for use in cosmetics, pharmaceuticals, and food industries. Operations are centered on formulation and distribution of these chemical solutions. The company is led by CEO Ari Melamud. Its online presence is maintained through the domain sharon-labs.com, supporting global outreach from the Israeli base.
- Headquarters Ashdod, Israel
- Stage Acquired
- SectorsChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website sharon-labs.com
- Social LinkedIn X Facebook YouTube
- Acquired by Tene Investment Funds (Mar 2017)
- Legal Name Iblbet Incorporated
- Investors
- Investments & Acquisitions
- Acquired byTene Investment Funds
(Mar 2017)
Apps and channels of Sharon Laboratories
its YouTube channel Lazada Indonesia has 13.5K subscribers and 30 videos.
Videos from Sharon Laboratories
The most watched videos on Sharon Laboratories's YouTube channel, Lazada Indonesia (13.5K subscribers). Click a video to play it here.
More on Lazada Indonesia.
Investors in Sharon Laboratories
Sharon Laboratories has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Tene Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tene Capital is recognized as a leading private equity fund in Israel. | 2005 | tenecapital.com | Tel Aviv, Israel |
Investor details for Sharon Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sharon Laboratories
2 people are tracked at Sharon Laboratories (2 in leadership).
| Name | Role | Group |
|---|---|---|
Ari Melamud | CEO | Leadership |
Naama Eylon | CEO | Leadership |
Complete people profiles for Sharon Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sharon Laboratories
Sharon Laboratories has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Res Pharma Innovative Ingredients.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Research and production of speciality ingredients for cosmetics are conducted. | respharmaind.com | Milan, Italy | 2004 | Mar 2022 | β’β’β’β’ |
Complete acquisition details for Sharon Laboratories
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sharon Laboratories
3 dated milestones of Sharon Laboratories across 45 years, from founding to its latest funding, stage changes and deals.
- Founded Sharon Laboratories is founded.
- Exit Acquired by Tene Investment Funds.
- Acquisition Acquires Res Pharma Innovative Ingredients.
Web traffic of Sharon Laboratories
Websites that share an audience with Sharon Laboratories (sharon-labs.com).
Websites whose visitors overlap most with Sharon Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
msnlabs.com | msnlabs.com | 100% | #620,052 | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sharon Laboratories
Complete news archive for Sharon Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sharon Laboratories
Sharon Laboratories was founded in 1977.
Sharon Laboratories is headquartered in Ashdod, Israel. It is registered at Ashdod, Southern District, Israel.
Ari Melamud is the CEO of Sharon Laboratories, as recorded in our data.
Sharon Laboratories was founded in 1977 in Ashdod, Israel, within the chemical sector. Diversified preservatives are developed and provided for use in cosmetics, pharmaceuticals, and food industries. Operations are centered on formulation and distribution of these chemical solutions. The company is led by CEO Ari Melamud. Its online presence is maintained through the domain sharon-labs.com, supporting global outreach from the Israeli base.
Sharon Laboratories has made 1 acquisition, including Res Pharma Innovative Ingredients.
Sharon Laboratories has 1 investor. Key investors include Tene Capital.
Sharon Laboratories operates through Iblbet Incorporated.
Yes. Sharon Laboratories was acquired by Tene Investment Funds in March 2017.

